欧洲人工血液替代品市场 – 行业趋势和 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Europe Artificial Blood Substitutes Market
请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

欧洲人工血液替代品市场 – 行业趋势和 2028 年预测

  • Healthcare
  • Published Report
  • Jul 2021
  • Europe
  • 350 页面
  • 桌子數： 54
  • 图号： 25
  • Author : Sachin Pawar
立即购买 立即购买 索取樣品 索取樣品
Nucleus Nucleus

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

欧洲人工血液替代品市场，按产品类型（全氟碳 (PFC) 和基于血红蛋白的氧载体 (HBOC)）、来源（人血、动物血、基于微生物的重组 HB、合成聚合物和干细胞）、应用（心血管疾病、恶性肿瘤、损伤、新生儿疾病、器官移植和产妇疾病）、最终用户（医院和诊所、血库等）、国家（法国、俄罗斯、荷兰、欧洲其他地区）划分，行业趋势和预测到 2028 年。

欧洲人造血液替代品市场市场分析与洞察：欧洲人工血液替代品市场

预计人工血液替代品市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 24.7%，预计到 2028 年将达到 9,028.24 万美元。新鲜血液的供应有限及其短暂的寿命，再加上对输血的需求不断增加以及对血液替代品开发资金的增加，成为人工血液替代品市场增长的驱动力。

人工血液替代品又称为氧疗法或血红蛋白氧载体。它用于模拟生物血液的功能，并提供输血替代品。人工血液是替代库存红细胞输血的解决方案，旨在克服血液供应不足、高风险污染、交叉配血要求等局限性。同种异体输血具有多重风险，可导致传染病传播、输血反应、输血相关急性肺损伤、术后伤口愈合延迟、免疫调节和癌症复发的潜在风险。它为新的、重要的救命医疗方法带来了希望。

人造血液的来源包括动物血液、人类血液、微生物重组血红蛋白、干细胞等。人造血液还具有多种优于人类血液的优势，因为它属于通用血型，可以输给任何血型的患者。此外，人造血液替代品不会产生任何免疫反应。此外，人造血液替代品消除了输血过程中感染疾病或污染的风险，并且与人类血液相比，人造血液替代品的保质期更长，因为它可以在室温下保存 3 年或更长时间，而人类血液的保质期仅为 42 天。人造血液可用于紧急情况，并且易于储存，对于因宗教信仰而不接受献血的患者来说，人造血液也是完美的选择。

新鲜血液供应有限且寿命短，再加上输血需求不断增长以及血液替代品开发资金不断增加，是推动欧洲人造血液替代品市场发展的关键因素。然而，人造血液的高成本以及政府机构对血液替代品产品审批的严格规定可能会阻碍人造血液替代品市场的增长。此外，人们对人造血液优势的认识不断提高，对人造血液的需求不断增加，再加上献血者数量不足以及人造血液研究和开发的数量不断增加，将为欧洲人造血液替代品市场创造巨大的机会。人造血液产品的缺乏、临床试验延长以及人造血液的副作用将给欧洲人造血液替代品市场带来巨大挑战。

人造血液替代品市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和人造血液替代品市场情景，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预​​期目标。

欧洲人造血液替代品市场人造血液替代品市场范围和市场规模

人造血液替代品市场根据产品类型、来源、应用和最终用户进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

  • 根据产品类型，欧洲人造血液替代品市场细分为全氟碳 (PFC) 和基于血红蛋白的氧载体 (HBOC)。全氟碳 (PFC) 进一步细分为全氟碳。基于血红蛋白的氧载体 (HBOC) 进一步细分为氧红蛋白和纯血红蛋白。2021 年，由于对血液替代品的需求不断增长，消除了血型并克服了人类血液短缺，基于血红蛋白的氧载体 (HBOC) 部分预计将在人造血液替代品市场中占据主导地位。
  • 根据来源，欧洲人造血液替代品市场分为人类血液、动物血液、基于微生物的重组 HB、合成聚合物和干细胞。由于有充足的来源可用于生产人造血液，预计 2021 年动物血液将主导人造血液替代品市场。
  • 根据应用，欧洲人造血液替代品市场细分为心血管疾病、恶性肿瘤、伤害、新生儿疾病、器官移植和产妇疾病。2021 年，由于伤害、道路交通事故等发生率上升，以及对治疗这些疾病的人造血液需求旺盛，预计伤害领域将主导人造血液替代品市场。
  • 根据最终用户，欧洲人造血液替代品市场分为医院和诊所、血库和其他。2021 年，由于患有各种疾病的患者数量不断增加，对血液的需求不断增长，预计医院和诊所部门将主导人造血液替代品市场。

人造血液替代品市场国家层面分析

对人工血液替代品市场进行了分析，并按上述国家、产品类型、来源、应用和最终用户提供了市场规模信息。

人工血液替代品市场报告涉及的国家包括法国、俄罗斯、荷兰和欧洲其他国家。

由于患者人数增加导致输血需求增加，预计法国的产品类型细分市场将在 2021 年至 2028 年的预测期内以最高增长率增长。由于治疗患者人数增加而人血供应有限，俄罗斯的产品类型细分市场占据市场主导地位。由于荷兰创伤病例和血液相关疾病发病率增加，荷兰的产品类型细分市场在欧洲市场中处于领先地位，因此荷兰的产品类型细分市场在该国占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

主要市场参与者不断增加的战略活动提高了人们对人工血液替代品的认识，从而推动了人工血液替代品市场的增长。

人造血液替代品市场还为您提供每个国家特定市场增长的详细市场分析。此外，它还提供有关市场参与者战略及其地理分布的详细信息。数据适用于 2010 年至 2019 年的历史时期。

竞争格局和人工血液替代品市场份额分析

人造血液替代品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对人造血液替代品市场的关注有关。

从事人工血液替代品业务的主要公司包括 HEMARINA、Hemoglobin Oxygen Therapeutics LLC、KaloCyte, Inc.、LLC “Visusmed”、欧洲药品管理局、OPK Biotech LLC、NuvOx Pharma、Prolong Pharmaceuticals, LLC、Boston Therapeutics, Inc.、Aurum Biosciences、OXYVITA Inc.、NanoBlood LLC 以及其他国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。

全球各地的公司也纷纷展开扩张和融资活动，加速人工血液替代品市场的发展。

例如，

  • 2020 年 11 月，Hemarina 发表了一份关于 M 101（一种用于治疗牙周炎的氧气转运蛋白）的抗炎和抗菌特性的科学报告。这项研究验证了 M 101 分子的质量，该分子源自海洋沙蚕的血红蛋白。
  • 2020 年 6 月，KaloCyte, Inc. 从马里兰大学系统 (USM) 动力基金获得了 30 万美元的资金，用于开发 ErythroMer，这是一种合成的、仿生的红血球替代品。这笔资金帮助该公司以更快的速度开发 ErythroMer。
  • 2020 年 5 月，KaloCyte, Inc. 获得了美国国立卫生研究院 (NIH) 颁发的 373,000 美元小企业创新研究 (SBIR) 第一阶段拨款。这笔拨款帮助该公司推进 KaloCyte 产品进行临床前安全性和有效性测试，以备进行人体试验。

市场参与者的合作、业务扩展、奖励和认可、合资企业等策略正在增强公司在人工血液替代品市场的影响力，这也为组织的利润增长带来了好处。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET
    4. LIMITATIONS
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. Currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. primary interviews with key opinion leaders
    7. MULTIVARIATE MODELLING
    8. PRODUCT TYPE LIFELINE CURVE
    9. DBMR MARKET POSITION GRID
    10. market APPLICATION coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
  5. PATENT ANALYSIS OF EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET
    1. DBMR ANALYSIS
    2. COUNTRY-LEVEL ANALYSIS
    3. YEARWISE ANALYSIS
  6. EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: PIPELINE ANALYSIS
  7. Market Overview
    1. drivers
      1. IncreasE IN demand for blood transfusion
      2. Increased funding for product development
      3. rise in blood-related disorders and trauma cases
      4. limited availability of fresh blood and small storage periods of fresh blood
    2. Restraints
      1. stringent regulatory approval process
      2. high-cost production of artificial blood substitute
      3. unawareness about the artificial blood substitutes
    3. OPPORTUNITIES
      1. increase in awareness regarding the advantages of artificial blood over human blood
      2. risE IN demand for blood substituteS and insufficient number of blood donors
      3. RISE IN number of research & developments on artificial blood
      4. ample amount of sources for production of artificial blood substitute
    4. Challenges
      1. instability of artificial blood product
      2. extended clinical trails
      3. side effects of artificial blood substitutes
  8. IMPACT OF COVID-19 ON THE EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET
    1. Aftermath of COVID-19
    2. Impact on Supply and Demand
    3. The increasing demand for blood transfusion is leading the artificial blood substitutes market.
    4. Conclusion
  9. Europe Artificial blood substitutes market, by Product Type
    1. overview
    2. Hemoglobin-Based Oxygen Carries (HBOCS)
      1. oxyglobin
      2. hemopure
    3. Perfluorocarbon (PFCS)
      1. perftoran
      2. others
  10. Europe Artificial blood substitutes market, by Source
    1. overview
    2. animal blood
    3. Human Blood
    4. Microorganism Based Recombinant Hb
    5. Stem Cells
    6. Synthetic Polymers
  11. Europe Artificial blood substitutes market, by Application
    1. overview
    2. injuries
    3. Cardiovascular Diseases
    4. Organ Transplant
    5. Maternal Condition
    6. Malignant Neoplasma
    7. Neonatal Conditions
  12. Europe Artificial blood substitutes market, by End user
    1. overview
    2. hospital and clinics
    3. blood banks
    4. others
  13. Europe Artificial blood SUBSTITUTEs MARKET, by Region
    1. EUROPE
      1. FRANCE
      2. RUSSIA
      3. NETHERLAND
      4. U.K.
      5. REST OF EUROPE
  14. Europe artificial blood substitutes market: COMPANY landscape
    1. company share analysis: Europe
  15. swot
  16. company profile
    1. kalocyte, inc.
      1. COMPANY SNAPSHOT
      2. Company sahre Analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    2. hemarina
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    3. hemoglobin oxygen therapeutics llc
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    4. llc “visusmed”
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENT
    5. European Medicines Agency
      1. COMPANY SNAPSHOT
      2. Revenue Analysis
      3. company share analysis
      4. PRODUCT PORTFOLIo
      5. RECENT DEVELOPMENT
    6. aurum biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENTS
    7. boston therapeutics, inc.
      1. COMPANY SNAPSHOT
      2. Revenue Analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENT
    8. nanoblood llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    9. nuvox pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENTS
    10. opk biotech llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    11. oxyvita inc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    12. prolong pharmaceuticals, llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

表格列表

TABLE 1 Europe Artificial blood substitutes Market, Product Type, 2019-2028 (USD Thousand)

TABLE 2 Europe Hemoglobin-Based Oxygen Carries (HBOCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 3 Europe HEMOGLOBIN-based oxygen carriers (HBOCs) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)

TABLE 4 Europe Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 5 Europe Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)

TABLE 6 Europe Artificial blood substitutes Market, by Source, 2019-2028 (USD Thousand)

TABLE 7 Europe animal blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 8 Europe human blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 9 Europe microorganism based recombinant hb in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 10 Europe stem cells in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 11 Europe synthetic polymers in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 12 Europe Artificial blood substitutes Market, by Application, 2019-2028 (USD Thousand)

TABLE 13 Europe injuries in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 14 Europe cardiovascular diseases in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 15 Europe organ transplant in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 16 Europe maternal condition in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 17 Europe malignant neoplasma in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 18 Europe neonatal conditions in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 19 Europe Artificial blood substitutes Market, by End user, 2019-2028 (USD Thousand)

TABLE 20 Europe hospitals and clinics in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 21 Europe blood banks in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 22 Europe others in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 23 Europe artificial blood substitute Market, By COUNTRY, 2019-2028 (USD Thousand)

TABLE 24 EUROPE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 25 Europe Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 26 Europe Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 27 Europe artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 28 Europe artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 29 Europe artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 30 FRANCE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 31 FRANCE Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 32 FRANCE Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 33 FRANCE artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 34 FRANCE artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 35 FRANCE artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 36 RUSSIA artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 37 RUSSIA Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 38 RUSSIA Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 39 RUSSIA artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 40 RUSSIA artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 41 RUSSIA artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 42 NETHERLAND artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 43 NETHERLAND Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 44 NETHERLAND Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 45 NETHERLAND artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 46 NETHERLAND artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 47 NETHERLAND artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 48 U.K. artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 49 U.K. Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 50 U.K. Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 51 U.K. artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 52 U.K. artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 53 U.K. artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 54 REST OF EUROPE ARTIFICIAL blood substitute Market, By Product type, 2019-2028 (USD Thousand)

图片列表

FIGURE 1 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: segmentation

FIGURE 2 Europe artificial blood substitutes market: data triangulation

FIGURE 3 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: DROC ANALYSIS

FIGURE 4 Europe artificial blood substitutes market: EUROPE vs REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: market APPLICATION COVERAGE GRID

FIGURE 9 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET: SEGMENTATION

FIGURE 11 increased DEMAND FOR BLOOD TRANSFUSION is expected to drive the Europe artificial blood substitutes market in THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 haemoglobin-based oxygen carriers (hbocs) SEgment is expected to account for the largest share of the EUROPE ARTIFICIAL BLOOD SUBSTITUTES MARKET in 2021 & 2028

FIGURE 13 PATENT REGISTERED FOR ARTIFICIAL BLOOD SUBSTITUTES, BY COUNTRY

FIGURE 14 PATENT REGISTERED YEAR (2017 - 2021)

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF EUROPE artificial blood substituteS MARKET

FIGURE 16 Europe Artificial blood substitutes Market, By Product Type, 2020

FIGURE 17 Europe Artificial blood substitutes Market, By Source, 2020

FIGURE 18 Europe Artificial blood substitutes Market, By Application, 2020

FIGURE 19 Europe Artificial blood substitutes Market, By End user, 2020

FIGURE 20 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: SNAPSHOT (2020)

FIGURE 21 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020)

FIGURE 22 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2021 & 2028)

FIGURE 23 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020 & 2028)

FIGURE 24 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY product type (2021-2028)

FIGURE 25 Europe artificial blood substitutes market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

浏览相关页面

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future